


Searching News Database: Trius Therapeutics
HSMN NewsFeed - 3 May 2016
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
HSMN NewsFeed - 11 Jul 2007
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
HSMN NewsFeed - 4 Jun 2007
Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts
Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts
HSMN NewsFeed - 26 Feb 2007
Trius Therapeutics Enters into License Agreement with Dong-A Pharmaceuticals for Novel Anti-bacterial Agent
Trius Therapeutics Enters into License Agreement with Dong-A Pharmaceuticals for Novel Anti-bacterial Agent
HSMN NewsFeed - 26 Feb 2007
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
